NCT00000945 - A Study to Evaluate the Use of Cidofovir (an Experimental Drug) for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) in AIDS Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

March 31, 2001

Conditions

HIV InfectionsLeukoencephalopathy, Progressive Multifocal

Interventions

DRUG

Cidofovir

DRUG

Probenecid

Trial Locations (19)

10003

Beth Israel Med Ctr, New York

10016

Bellevue Hosp / New York Univ Med Ctr, New York

10029

Mount Sinai Med Ctr, New York

14215

SUNY / Erie County Med Ctr at Buffalo, Buffalo

14642

Univ of Rochester Medical Center, Rochester

20059

Howard Univ, Washington D.C.

21287

Johns Hopkins Hosp, Baltimore

29169

Julio Arroyo, West Columbia

35294

Univ of Alabama at Birmingham, Birmingham

45267

Univ of Kentucky Lexington, Cincinnati

60611

Northwestern Univ Med School, Chicago

60612

Cook County Hosp, Chicago

Rush Presbyterian - Saint Luke's Med Ctr, Chicago

60640

Louis A Weiss Memorial Hosp, Chicago

80262

Univ of Colorado Health Sciences Ctr, Denver

98104

Univ of Washington, Seattle

275997215

Univ of North Carolina, Chapel Hill

941102859

San Francisco AIDS Clinic / San Francisco Gen Hosp, San Francisco

San Francisco Gen Hosp, San Francisco

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH